Impact of Follicle-Stimulating Hormone and Human Menopausal Gonadotropin Dosage Ratios on Echogenicity and Progesterone Concentrations in In Vitro Fertilization Patients.

被引：0
|
作者：
Magarelli, Paul C. [1 ]
Kiltz, Robert [2 ]
Moffitt, Drew [3 ]
Decherney, Alan [4 ]
机构：
[1] Genesis Network Reprod Hlth, Irvine, CA USA
[2] Reprod Med & Fertil Ctr, Colorado Springs, CO USA
[3] CNY Fertil, Syracuse, NY USA
[4] Arizona Reprod Med, Phoenix, AZ USA
来源：
FERTILITY AND STERILITY | 2010年 / 93卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：S17 / S17
页数：1
相关论文
共 50 条
  • [1] Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome
    Strehler, E
    Abt, M
    El-Danasouri, I
    De Santo, M
    Sterzik, K
    FERTILITY AND STERILITY, 2001, 75 (02) : 332 - 336
  • [2] Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis
    Agrawal, R
    Holmes, J
    Jacobs, HS
    FERTILITY AND STERILITY, 2000, 73 (02) : 338 - 343
  • [3] Effects of reduced follicle-stimulating hormone dosage before human chorionic gonadotropin trigger on in vitro fertilization outcomes
    Zhanhui Ou
    Jing Du
    Nengqing Liu
    Jieliang Li
    Xiufeng Lin
    BMC Pregnancy and Childbirth, 23
  • [4] Effects of reduced follicle-stimulating hormone dosage before human chorionic gonadotropin trigger on in vitro fertilization outcomes
    Ou, Zhanhui
    Du, Jing
    Liu, Nengqing
    Li, Jieliang
    Lin, Xiufeng
    BMC PREGNANCY AND CHILDBIRTH, 2023, 23 (01)
  • [5] Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization
    Commenges-Ducos, M
    Piault, S
    Papaxanthos, A
    Ribes, C
    Dallay, D
    Commenges, D
    FERTILITY AND STERILITY, 2002, 78 (05) : 1049 - 1054
  • [6] Characteristics of consecutive in vitro fertilization cycles among patients treated with follicle-stimulating hormone (FSH) and human menopausal gonadotropin versus FSH alone
    Sills, ES
    Schattman, GL
    Veeck, LL
    Liu, HC
    Prasad, M
    Rosenwaks, Z
    FERTILITY AND STERILITY, 1998, 69 (05) : 831 - 835
  • [7] Recombinant follicle-stimulating hormone and in vitro fertilization
    Tarlatzis, BC
    Bili, H
    NEW HORIZONS IN REPRODUCTIVE MEDICINE, 1997, 12 : 295 - 299
  • [8] FOLLICLE-STIMULATING-HORMONE VERSUS HUMAN MENOPAUSAL GONADOTROPIN FOR IN-VITRO FERTILIZATION - RESULTS OF A METAANALYSIS
    DAYA, S
    HORMONE RESEARCH, 1995, 43 (05) : 224 - 229
  • [9] FOLLICLE-STIMULATING-HORMONE VERSUS HUMAN MENOPAUSAL GONADOTROPIN FOR IN-VITRO FERTILIZATION CYCLES - A METAANALYSIS
    DAYA, S
    GUNBY, J
    HUGHES, EG
    COLLINS, JA
    SAGLE, MA
    FERTILITY AND STERILITY, 1995, 64 (02) : 347 - 354
  • [10] Ovarian response and in vitro fertilization outcome in patients with reduced ovarian reserve who were stimulated with recombinant follicle-stimulating hormone or human menopausal gonadotropin
    Meo, F
    Ranieri, DM
    Khadum, I
    Serhal, P
    FERTILITY AND STERILITY, 2002, 77 (03) : 630 - 632
12345